Skip to main content
. 2023 May 18;14:1158659. doi: 10.3389/fmicb.2023.1158659

TABLE 1.

Mics of antibiotics and compounds.

Category Antibiotics MIC (μ g/mL)/antimicrobial susceptibility
Ec15103 Ec600 EPI300 Ec15103
-Ec600
Ec15103-
EPI300-1
Ec15103-
EPI300-2
β-Lactams Ampicillin ≥32R ≤8S ≤8S ≥32R ≥32R ≥32R
Ampicillin/sulbactam =32/16R ≤2/1S ≤2/1S =32/16R =32/16R =32/16R
Cefazolin ≥8R ≤2S ≤2S ≥8R ≤2S ≥8R
Cefuroxime ≥32R ≤8S ≤8S ≥32R ≤8S ≥32R
Ceftriaxone ≥64R ≤1S ≤1S ≥64R ≤1S ≥64R
Cefotaxime ≥8R ≤4S ≤4S ≥8R ≤4S ≥8R
Cefotaxime/clavulanic acid ≤1/4S ≤1/4S ≤1/4S ≤1/4S ≤1/4S ≤1/4S
Ceftazidime =16R ≤4S ≤4S ≤4S ≤4S ≤4S
Ceftazidime/clavulanic acid ≤1/4S ≤1/4S ≤1/4S ≤1/4S ≤1/4S ≤1/4S
Cefoxitin ≤8S ≤8S ≤8S ≤8S ≤8S ≤8S
Cefepime ≥32R ≤2S ≤2S ≤2S ≤2S ≤2S
Piperacillin/tazobactam ≤4/4S ≤4/4S ≤4/4S ≤4/4S ≤4/4S ≤4/4S
Ticarcillin/clavulanic acid =64/2I ≤4/2S ≤4/2S =64/2I =64/2I =64/2I
Cefoperazone/sulbactam =16/8S ≤2/1S ≤2/1S =16/8S ≤2/1S =16/8S
Carbapenems Meropenem ≤1S ≤1S ≤1S ≤1S ≤1S ≤1S
Imipenem ≤1S ≤1S ≤1S ≤1S ≤1S ≤1S
Aminoglycosides Gentamicin ≥16R ≤1S ≤1S ≤1S ≥16R ≥16R
Amikacin ≤4S ≤4S ≤4S ≤4S ≤4S ≤4S
Fluoroquinolones Ciprofloxacin ≥4R ≤0.06S ≤0.06S ≤0.06S ≤0.06S ≤0.06S
Levofloxacin =4I ≤0.12S ≤0.12S ≤0.12S ≤0.12S ≤0.12S
Others Polymyxin B ≤2S ≤2S ≤2S ≤2S ≤2S ≤2S
Co-trimoxazole ≥8/152R ≤0.5/9.5S =4/76R ≤0.5/9.5S ≥8/152R ≥8/152R
Nitrofurantoin ≤16S ≤16S ≤16S ≤16S ≤16S ≤16S
Minocycline ≤4S ≤4S ≤4S ≤4S ≤4S ≤4S
Chloromycetin ≤8S ≤8S ≤8S ≤8S ≤8S ≤8S

S: susceptible; I: intermediate; R: resistant.